
CONMED Corporation CNMD
€ 38.93
-0.17%
Geschäftsbericht 2025
hinzugefügt 17.02.2026
CONMED Corporation Langfristige Verbindlichkeiten 2011-2026 | CNMD
Langfristige Verbindlichkeiten Jährlich CONMED Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 877 M | 546 M | 577 M | 634 M | 408 M | 401 M | 373 M | 355 M | 231 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 877 M | 231 M | 489 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
89.9 M | $ 14.04 | 0.79 % | $ 2.11 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 15.16 | 4.19 % | $ 410 M | ||
|
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 6.62 | 3.6 % | $ 475 M | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
AxoGen
AXGN
|
1.61 M | $ 31.22 | -3.94 % | $ 1.44 B | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
7.44 M | $ 4.59 | 2.68 % | $ 171 M | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.42 | -3.39 % | $ 118 M | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
Electromed
ELMD
|
8.87 K | $ 23.92 | 3.33 % | $ 202 M | ||
|
Bio-Rad Laboratories
BIO
|
1.35 B | $ 269.65 | 0.29 % | $ 7.61 B | ||
|
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 39.89 | 0.3 % | $ 5.94 K | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
11.8 B | $ 73.48 | -2.22 % | $ 109 B | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
IRadimed Corporation
IRMD
|
4.76 M | $ 100.5 | 1.42 % | $ 1.27 B | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
516 M | $ 70.29 | 1.8 % | $ 3.83 B | ||
|
InMode Ltd.
INMD
|
12.5 M | $ 13.96 | -0.14 % | $ 902 M | ||
|
Pulmonx Corporation
LUNG
|
25 M | $ 1.63 | 7.95 % | $ 63.8 M | ||
|
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | ||
|
Medtronic PLC
MDT
|
29.6 B | $ 96.65 | -0.1 % | $ 124 B | ||
|
MiMedx Group
MDXG
|
65.4 M | $ 5.28 | -1.31 % | $ 780 M | ||
|
Delcath Systems
DCTH
|
2.52 M | $ 10.21 | 2.61 % | $ 291 M | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
161 M | - | - | $ 10.2 M | ||
|
Myomo
MYO
|
275 K | $ 0.75 | 16.11 % | $ 5.29 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
6.91 M | $ 2.45 | 0.82 % | $ 144 M | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
Establishment Labs Holdings
ESTA
|
53.7 M | $ 78.29 | -1.73 % | $ 2.2 B | ||
|
Insulet Corporation
PODD
|
1.06 B | $ 248.12 | 1.17 % | $ 17.5 B | ||
|
Profound Medical Corp.
PROF
|
2.44 M | $ 7.4 | 3.5 % | $ 180 M | ||
|
Quanterix Corporation
QTRX
|
21.5 M | $ 6.29 | 10.35 % | $ 236 M |